A generic beginning with B has what classification?

• A. Has potential bioequivalence problems and MAY not produce the same therapeutic effect
• B. Has been given an 'equivalent' classification by the FDA
• C. Has an unknown status
• D. Has been declared unsafe for use

Answer: (A)

Biocompatibility of a generic with its brand depends on bioequivalence—the two products must reach similar blood levels of the active drug when given the same dose. In the FDA’s therapeutic equivalence framework, AB-rated products are considered therapeutically equivalent to the reference brand. A generic that carries a B designation signals potential bioequivalence problems and may not produce the same therapeutic effect because its absorption or overall exposure could differ from the brand. This is why the statement about possible bioequivalence issues and not delivering the same therapeutic effect is the best description. The other statuses imply proven equivalence (not the case here) or unknown/unsafe conditions, which don’t fit the B designation.